Medinex Limited

Catalist:OTX Stock Report

Market Cap: S$29.2m

Medinex Past Earnings Performance

Past criteria checks 1/6

Medinex's earnings have been declining at an average annual rate of -22.8%, while the Healthcare industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 1.3% per year. Medinex's return on equity is 9.1%, and it has net margins of 12.1%.

Key information

-22.8%

Earnings growth rate

-23.0%

EPS growth rate

Healthcare Industry Growth9.7%
Revenue growth rate1.3%
Return on equity9.1%
Net Margin12.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medinex makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

Catalist:OTX Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2413200
30 Jun 2413100
31 Mar 2413100
31 Dec 2312100
30 Sep 2312200
30 Jun 2312200
31 Mar 2313200
31 Dec 2213200
30 Sep 2214100
30 Jun 2213200
31 Mar 2212300
31 Dec 2112300
30 Sep 2112400
30 Jun 2111400
31 Mar 2111300
30 Sep 2011300
30 Jun 2012300
31 Mar 2013300
30 Jun 1911100
31 Mar 1910100
31 Dec 189100
30 Sep 188100
30 Jun 186100
31 Mar 185100
31 Dec 173100
31 Dec 162100
31 Dec 151000

Quality Earnings: OTX has high quality earnings.

Growing Profit Margin: OTX's current net profit margins (12.1%) are lower than last year (16.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OTX's earnings have declined by 22.8% per year over the past 5 years.

Accelerating Growth: OTX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: OTX had negative earnings growth (-20.3%) over the past year, making it difficult to compare to the Healthcare industry average (-26%).

Return on Equity

High ROE: OTX's Return on Equity (9.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:02
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medinex Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution